Aslan Fred sold ARTV
November 17, 2025 · Form 4 insider transaction
Aslan Fred sold 6,375 shares of Artiva Biotherapeutics, Inc. at $3.38 per share, a transaction worth $21.5K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
6,375
Price
$3.38
Total value
$21.5K
InsiderAslan Fred
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateNovember 17, 2025
Filing dateNovember 17, 2025
Shares owned after343,999
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on July 23, 2024.; The weighted average sale price for the transaction reported was $3.376, and the range of prices were between $3.19 and $3.53. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.